Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors.

Kearney MT, Nolan J, Lee AJ, Brooksby PW, Prescott R, Shah AM, Zaman AG, Eckberg DL, Lindsay HS, Batin PD, Andrews R, Fox KA.

Eur J Heart Fail. 2003 Aug;5(4):489-97.

2.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.

PMID:
17540211
3.

The effect of anemia on mortality in indigent patients with mild-to-moderate chronic heart failure.

Hebert K, Horswell R, Arcement L, Hare J, Stevenson L.

Congest Heart Fail. 2006 Mar-Apr;12(2):75-9.

5.

Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.

Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW.

J Am Coll Cardiol. 2003 Jun 4;41(11):2029-35.

6.

The rationale and indications for angiotensin receptor blockers in heart failure.

Bybee KA, Das S, O'Keefe JH.

Heart Fail Clin. 2006 Jan;2(1):81-8. Review. No abstract available.

PMID:
17386879
7.

The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.

Sharma R, Rauchhaus M, Ponikowski PP, Varney S, Poole-Wilson PA, Mann DL, Coats AJ, Anker SD.

J Am Coll Cardiol. 2000 Aug;36(2):523-8.

9.

[Prognosis of heart failure--value of drug therapy].

Felix SB.

Z Kardiol. 1996;85 Suppl 4:1-7. Review. German.

PMID:
9027102
10.

Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors.

Havranek EP, Abrams F, Stevens E, Parker K.

Arch Intern Med. 1998 Oct 12;158(18):2024-8.

PMID:
9778202
12.

[Heart failure: critical patients].

Fabbri G, Gorini M, Maggioni AP, Oliva F; ANMCO.

G Ital Cardiol (Rome). 2007 Sep;8(9):568-73. Italian.

PMID:
17972426
13.

A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.

Adewole AD, Ikem RT, Adigun AQ, Akintomide AO, Balogun MO, Ajayi AA.

Cent Afr J Med. 1996 Aug;42(8):253-5.

PMID:
8990572
15.

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R.

Arch Intern Med. 2000 Jan 10;160(1):53-60.

PMID:
10632305
16.
17.

Experience with beta blockers in heart failure mortality trials.

Eichhorn EJ.

Clin Cardiol. 1999 Oct;22 Suppl 5:V21-9. Review.

18.

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.

Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ.

J Am Coll Cardiol. 1993 Mar 1;21(3):655-61.

19.

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

Rydén L, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA.

Eur Heart J. 2000 Dec;21(23):1967-78.

PMID:
11071803
20.

Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.

Keyhan G, Chen SF, Pilote L.

Eur J Heart Fail. 2007 Jun-Jul;9(6-7):594-601. Epub 2007 Apr 25.

Supplemental Content

Support Center